Linköping University news release
HIV exhausts the body’s immune system by overactivating it, despite effective antiviral treatment. Researchers from Linköping University have conducted cell studies showing that an existing medication (anifrolumab) restores immune cell function. The findings raise hopes that this medication could improve the health of people living with HIV.
Anifrolumab blocks type 1 interferon and is used to treat systemic lupus erythematosus, an autoimmune disease.
Read the full news release here.
Source : Linköping University
Related HIV and Co-Infections News
-
NIH-funded breakthrough shrinks CRISPR for precision delivery in the body
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
UNC School of Medicine: Researchers demonstrate drug’s effectiveness in drawing out dormant HIV from immune cells
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.